Gambia vs World: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%)
Gambia
82.0%
in 2025
World
30.0%
in 2025
Gambia rank
3rd
World rank
4th
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) over time
- Gambia
- World
How they compare
Gambia currently reports 82.0% against 30.0% in World, a difference of 52.0%.
That makes Gambia's figure about 2.7 times World's.
The two have swapped places 1 time across 10 shared years of data; in 2016 it was World ahead.
Gambia ranks 3rd and World ranks 4th of 26 countries.
Across the 2 decades both report, Gambia averaged higher in 1 and World in 1.
Head to head by decade
| Decade | Gambia | World | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8.8% | 11.8% | 3.0% | World |
| 2020s | 75.3% | 28.0% | 47.3% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher meningococcal a conjugate (menga) vaccine immunization coverage (%), Gambia or World?
- Gambia, at 82.0% against 30.0% in World as of 2025.
- What is the difference in meningococcal a conjugate (menga) vaccine immunization coverage (%) between Gambia and World?
- 52.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and World?
- 10 years are reported by both, from 2016 to 2025.
- How do Gambia and World rank globally for meningococcal a conjugate (menga) vaccine immunization coverage (%)?
- Gambia ranks 3rd and World ranks 4th of 26 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.